<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Starling Oncology, Inc. (STLN) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/stln/</link>
<description>Every dated entry in the public record on Starling Oncology, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/stln/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Fri, 30 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Starling Oncology, Inc.: short interest 6,535,739 shares at the 15 October 2026 settlement, 5.62 days to cover</title><link>https://greeksoup.ai/stocks/us/stln/short-interest/</link><guid isPermaLink="false">us:STLN:short-interest:2026-10-15:86aa2a81a6</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: short interest 6,793,070 shares at the 30 September 2026 settlement, 4.31 days to cover</title><link>https://greeksoup.ai/stocks/us/stln/short-interest/</link><guid isPermaLink="false">us:STLN:short-interest:2026-09-30:3cafc3be47</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: short interest 7,053,920 shares at the 15 September 2026 settlement, 7.35 days to cover</title><link>https://greeksoup.ai/stocks/us/stln/short-interest/</link><guid isPermaLink="false">us:STLN:short-interest:2026-09-15:8b27bd671b</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. filed 8-K: officer or director change</title><link>https://greeksoup.ai/stocks/us/stln/filings/</link><guid isPermaLink="false">us:STLN:filing:2026-09-02:baf51b2e81</guid><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: short interest 6,816,792 shares at the 31 August 2026 settlement, 5.58 days to cover</title><link>https://greeksoup.ai/stocks/us/stln/short-interest/</link><guid isPermaLink="false">us:STLN:short-interest:2026-08-31:b8a6c1b6db</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: Hively Brad (Director) sold 298,853 shares (under a trading plan set in advance) at $6.51 on 21 August 2026, $1.9 million</title><link>https://greeksoup.ai/stocks/us/stln/insiders/</link><guid isPermaLink="false">us:STLN:insider:2026-08-24:688af6c2d9</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000107997326001175/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. filed 8-K: material agreement, new financial obligation</title><link>https://greeksoup.ai/stocks/us/stln/filings/</link><guid isPermaLink="false">us:STLN:filing:2026-08-21:f34a8c583f</guid><pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000107997326001169/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: Form 144, BRADFORD HIVELY plans to sell 298,853 shares worth $2.0 million around 21 August 2026</title><link>https://greeksoup.ai/stocks/us/stln/planned-sales/</link><guid isPermaLink="false">us:STLN:planned-sale:2026-08-21:b00877c6c7</guid><pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000195004726008532/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: Chernett Jorey (10% owner) bought 12,000 shares at $6.54 on 14 August 2026, $78,480</title><link>https://greeksoup.ai/stocks/us/stln/insiders/</link><guid isPermaLink="false">us:STLN:insider:2026-08-17:57c3d6e6f5</guid><pubDate>Mon, 17 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000092189526002203/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc.: short interest 6,884,302 shares at the 14 August 2026 settlement, 3.51 days to cover</title><link>https://greeksoup.ai/stocks/us/stln/short-interest/</link><guid isPermaLink="false">us:STLN:short-interest:2026-08-14:23714c1be7</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. Q2 FY2026 results: revenue $161 million, net income -$10 million</title><link>https://greeksoup.ai/stocks/us/stln/results/fy2026-q2/</link><guid isPermaLink="false">us:STLN:result:2026-08-06:851344fc48</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001799191&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/stln/filings/</link><guid isPermaLink="false">us:STLN:filing:2026-08-06:5a41afb04f</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000179919126000017/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/stln/filings/</link><guid isPermaLink="false">us:STLN:filing:2026-08-06:4472ad0b4d</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000107997326001006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Starling Oncology, Inc. filed 8-K: charter or bylaw amendment, or fiscal year change, regulation fd disclosure</title><link>https://greeksoup.ai/stocks/us/stln/filings/</link><guid isPermaLink="false">us:STLN:filing:2026-08-03:977ed4ae8a</guid><pubDate>Mon, 03 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1799191/000107997326000997/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/stln/filings/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
